TETRAPHASE PHARMACEUTICALS, INC. Up to $40,000,000 Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementTetraphase Pharmaceuticals Inc • January 17th, 2017 • Pharmaceutical preparations • New York
Tetraphase Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
